As of November 2026 Iovance Biotherapeutics has a market cap of A$5.45 Billion. This makes Iovance Biotherapeutics the world's 3640th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On Oct 31st, 2026 the market cap of Iovance Biotherapeutics was reported to be: